Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 3 NIH 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1 Lymphoid 1 Head & Neck 1 Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 513 Breast Neoplasms, Male 79 Ovarian Neoplasms 54 Triple Negative Breast Neoplasms 46 Lung Neoplasms 43 Colonic Neoplasms 41 Prostatic Neoplasms 38 Neoplasms 38 Neoplasm Metastasis 35 Carcinoma, Non-Small-Cell Lung 33 Melanoma 31 Pancreatic Neoplasms 29 Colorectal Neoplasms 28 Stomach Neoplasms 24 Carcinoma, Ovarian Epithelial 24 Endometrial Neoplasms 23 Carcinoma, Renal Cell 23 Inflammatory Breast Neoplasms 21 Brain Neoplasms 20 Carcinoma, Intraductal, Noninfiltrating 19 Breast Carcinoma In Situ 19 Rectal Neoplasms 18 Urinary Bladder Neoplasms 17 Lymphoma, Non-Hodgkin 17 Lymphoma, T-Cell, Cutaneous 16 Leukemia, Lymphocytic, Chronic, B-Cell 16 Esophageal Neoplasms 16 Uterine Cervical Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Lymphoma 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Hyperplasia × Breast × Clear all

NCT00339248 2009-03-13

Markers for Breast Cancer

National Institutes of Health Clinical Center (CC)

Breast Neoplasms, Hyperplasia, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡